Similar findings have also been reported in GBM, where the antibody blockade of SEMA3A was found to downregulate the PI3K/AKT pathway, inhibiting tumour growth and the recruitment of macrophages to the tumour site [57]. This evidence concerns the gene SEMA3A and neoplasm.